I use the USAToday as a bellweather for public information. By the time they get a story out, it should be in the public conciousness.
Take a look at the companies that are attracting attention. These are the ones with sales. These are the ones with revenue, and could either blow things out with the protection of a major biotech, or an infusion of capital via the public markets.
The ones that are long term research, well they're going to have trouble.
Lots of trouble.